Holen Sie sich die Stockscreener-App
162.11
1.04%
1.67
Handel nachbörslich:
162.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$160.44
Offen:
$160.88
24-Stunden-Volumen:
844.29K
Relative Volume:
1.15
Marktkapitalisierung:
$18.09B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
24.34
EPS:
6.66
Netto-Cashflow:
$1.02B
1W Leistung:
+1.21%
1M Leistung:
+8.33%
6M Leistung:
+12.31%
1J Leistung:
+20.18%
1-Tages-Spanne:
$160.76
$162.72
1-Wochen-Bereich:
$156.10
$162.72
52-Wochen-Spanne:
$123.04
$162.72
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| DGX | 162.11 | 18.09B | 9.54B | 841.00M | 1.02B | 6.66 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Sets New 1-Year HighHere's Why - MarketBeat
Quest Diagnostics stock hits 52-week high of $162.68 By Investing.com - Investing.com Canada
IVY Lane Capital Management LLC Has $8.85 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology - Benzinga
Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Mizuho Securities USA LLC - MarketBeat
ING Groep NV Grows Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 4,223 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management - BioSpace
Q3 EPS Estimates for Quest Diagnostics Cut by Zacks Research - MarketBeat
Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
January 2025 Options Now Available For Quest Diagnostics (DGX) - Nasdaq
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy - Yahoo Finance
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Arjuna Capital - MarketBeat
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now? - Yahoo Finance
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Lessened by Van ECK Associates Corp - MarketBeat
Quest Diagnostics Declares Quarterly Cash Dividend - Nasdaq
Here's Why You Should Retain DGX Stock in Your Portfolio Now - MSN
Victory Capital Management Inc. Sells 419,365 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Versor Investments LP Acquires 3,583 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics (NYSE:DGX) Hits New 12-Month HighStill a Buy? - MarketBeat
Quest Diagnostics stock hits 52-week high of $161.1 By Investing.com - Investing.com Canada
Kennebec Savings Bank Buys Shares of 3,823 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Amalgamated Bank Has $3.39 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Asset Management One Co. Ltd. Grows Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Downgraded by StockNews.com to Hold - MarketBeat
Quest Diagnostics Inc. stock rises Thursday, still underperforms market - MarketWatch
Quest Diagnostics Driver Reveals Life-Changing Career Switch in Healthcare Logistics | DGX Stock News - StockTitan
Olstein Capital Management L.P. Lowers Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
National Pension Service Buys 11,085 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock rises Wednesday, still underperforms market - MarketWatch
Quest Diagnostics (DGX) Declares $0.71 Dividend - MSN
Harbor Capital Advisors Inc. Purchases 5,436 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Nonprofit Partners With Newark Black Churches To Bridge Health Disparities - StockTitan
Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by QRG Capital Management Inc. - MarketBeat
New York State Teachers Retirement System Trims Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
DGX (Quest Diagnostics) PE Ratio : 20.87 (As of Nov. 02, 2024) - GuruFocus.com
Cambiar Investors LLC Has $13.75 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by State of Alaska Department of Revenue - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Holdings Lowered by Assenagon Asset Management S.A. - MarketBeat
Quest Diagnostics (NYSE:DGX) Upgraded at StockNews.com - MarketBeat
Quest Diagnostics' SVP sells shares worth $278,525 By Investing.com - Investing.com Canada
Quest Diagnostics' SVP sells shares worth $278,525 - Investing.com India
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):